Verona Pharma plc (VRNA) ADR EACH REP 8 ORD SHS SPON
Sell:$14.88Buy:$14.90
$0.10 (0.68%)
- This stock can be held in a
Stocks and Shares ISA
SIPPSell:$14.88
Buy:$14.90
Change:$0.10 (0.68%)
$0.10 (0.68%)Prices delayed by at least 15 minutes
Sell:$14.88
Buy:$14.90
Change:$0.10 (0.68%)
$0.10 (0.68%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 3 May 2024 | Kathleen A. (Kathy) RickardOther Level A | Sell Regular sell transaction (market) | 36,248 | $1.96 | $71,031.58 | 2,621,552 |
| 1 May 2024 | David Scott ZaccardelliPresident/CEO | Sell Tax related | 88,544 | $1.93 | $171,005.03 | 15,854,048 |
| 1 May 2024 | Mark W HahnCFO | Sell Tax related | 88,544 | $1.93 | $171,005.03 | 14,943,032 |
| 1 May 2024 | Kathleen A. (Kathy) RickardOther Level A | Sell Tax related | 73,824 | $1.93 | $142,576.29 | 2,657,800 |
| 5 February 2024 | Kathleen A. (Kathy) RickardOther Level A | Sell Regular sell transaction (market) | 36,248 | $2.22 | $80,503.18 | 2,731,624 |
| 1 February 2024 | David Scott ZaccardelliPresident/CEO | Sell Tax related | 480,200 | $2.29 | $1,101,482.76 | 15,942,592 |
| 1 February 2024 | Mark W HahnCFO | Sell Tax related | 480,664 | $2.29 | $1,102,547.08 | 15,031,576 |
| 1 February 2024 | Kathleen A. (Kathy) RickardOther Level A | Sell Tax related | 72,768 | $2.29 | $166,915.24 | 2,767,872 |
| 1 February 2024 | Claire Louise PollGeneral Counsel | Sell Tax related | 103,408 | $2.29 | $237,197.27 | 1,740,079 |
| 20 November 2023 | Martin William EdwardsIndependent Director | Buy Regular purchase transaction | 33,736 | $1.84 | $61,973.03 | 144,800 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 15 May 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 345,313 | $20.00 | $6,906,260.00 | 3,777,778 |
| 11 May 2023 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 80,000 | $22.26 | $1,780,800.00 | 4,180,691 |
| 1 November 2023 | David Scott ZaccardelliPresident/CEO | Sell Tax related | 809,008 | $1.74 | $1,410,748.15 | 16,422,792 |
| 1 November 2023 | Mark W HahnCFO | Sell Tax related | 809,008 | $1.74 | $1,410,748.15 | 15,512,240 |
| 1 February 2024 | Mark W HahnCFO | Sell Tax related | 480,664 | $2.29 | $1,102,547.08 | 15,031,576 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.